March 21, 2022 -- The FDA contiguous announced its vaccines advisory committee volition conscionable April 6 to sermon the aboriginal of COVID-19 booster doses and however to archer if a circumstantial strain of the coronavirus needs its ain vaccine.
The autarkic experts connected the Vaccines and Related Biological Products Advisory Committee volition beryllium joined by representatives from the CDC and the National Institutes of Health. According to a connection from the FDA, nary votes volition beryllium taken and nary circumstantial company’s vaccines volition beryllium discussed.
“As we hole for aboriginal needs to code COVID-19, prevention successful the signifier of vaccines remains our champion defence against the illness and immoderate perchance terrible consequences,” Peter Marks, MD, PhD, manager of the FDA’s Center for Biologics Evaluation and Research, said successful the statement.
Experts astatine the gathering volition sermon what mightiness marque them alteration the vaccine formulas to people circumstantial variants and erstwhile a booster dose should beryllium fixed and to whom.
Infectious illness specialists are watching BA.2, the Omicron subvariant that appears to beryllium much transmissible than the archetypal strain. BA.2 is driving outbreaks crossed Europe and is becoming much communal crossed the U.S.
BA.2 accounted for 23% of caller COVID-19 cases for the week ending March 12, according to the latest estimate from the CDC, up from...